Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Litigation Update

17 May 2022 07:02

RNS Number : 7448L
Nanoco Group PLC
17 May 2022
 

FOR IMMEDIATE RELEASE 17 May 2022

Nanoco Group PLC

("Nanoco, the "Group", or the "Company")

 

Litigation Update - PTAB uphold all 47 Nanoco patent claims

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, announces a significant update to its litigation against Samsung for the willful infringement of the Group's IP.

 

The US Patent Trial and Appeal Board ('PTAB') has ruled in favour of Nanoco in respect of all 47 claims in the five patents that were subject to inter partes review (IPRs) in the case.

 

As previously announced, Samsung had applied to the PTAB requesting the institution of IPRs of each of the five patents in the case. An IPR is a standard part of IP litigation and examines the validity of the patents themselves. It often runs in parallel with the judicial process. In May 2021, PTAB announced its decision to institute IPRs over the five patents.

 

The Board and its advisers are reviewing the detailed ruling by the PTAB with respect to all of the claims and patents. While Samsung can be expected to appeal the final PTAB decisions, the Company believes it is likely that the stay on the court process will now be lifted at the hearing scheduled for 2 June 2022 in the Eastern District of Texas. If the stay is lifted, pre-trial motions will then be considered by the judge and the Company expects a revised trial date to be scheduled for the fourth quarter of calendar year 2022.

 

Brian Tenner, Chief Executive Officer of Nanoco Group plc, said:

"The strength of Nanoco's case has been amply demonstrated by the PTAB finding in favour of every single one of the 47 claims under the five patents. The question of the validity of our intellectual property has now been very clearly resolved in favour of Nanoco.

 

"As a result, the trial can now focus on the issue of Samsung's alleged wilful infringement and the appropriate level of damages.

 

"Nanoco has overcome the first of two major hurdles in the litigation, the validity of our IP. As a result, our confidence in this case has increased further. While there is still much to be done, successfully overcoming this hurdle allows a straight run in to a trial later in 2022. A favourable trial outcome should then deliver a substantial inflection point for Nanoco's prospects and shareholder value."

 

- Ends -

 

For further information, please contact:

Nanoco Group PLC:

Brian Tenner, CEO +44 (0) 161 603 7900

Liam Gray, CFO & Company Secretary +44 (0) 161 603 7900

 

Peel Hunt:

Edward Knight +44 (0) 20 7418 8900

James Smith

 

MHP Communications: +44 (0) 203 128 8990

Reg Hoare

Pete Lambie

Charlie Protheroe

nanoco@mhpc.com 

 

The person responsible for arranging for the release of this announcement on behalf of Nanoco is Liam Gray, Company Secretary.

MAR

This Announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

FORWARD LOOKING STATEMENTS

This announcement (including information incorporated by reference in this announcement) and other information published by Nanoco may contain statements about Nanoco that are or may be deemed to be forward looking statements. Such statements are prospective in nature. All statements other than historical statements of facts may be forward looking statements. Without limitation, statements containing the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or "considers" or other similar words may be forward looking statements.

Forward looking statements inherently contain risks and uncertainties as they relate to events or circumstances in the future. Important factors such as business or economic cycles, the terms and conditions of Nanoco's financing arrangements, tax rates, or increased competition may cause Nanoco's actual financial results, performance or achievements to differ materially from any forward looking statements. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Nanoco disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFIRELIDLIF
Date   Source Headline
4th Dec 20177:00 amRNSCommercial Supply and License Agreement
30th Nov 20174:43 pmRNSSecond Price Monitoring Extn
30th Nov 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:31 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Financial Report
16th Nov 20174:50 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSPreliminary Results
15th Nov 201710:42 amRNSDirector/PDMR Shareholding
14th Nov 20171:38 pmRNSResult of General Meeting
14th Nov 20177:00 amRNSWebcast of Full Year Results
8th Nov 201712:08 pmRNSHolding(s) in Company
2nd Nov 201710:35 amRNSHolding(s) in Company
1st Nov 20177:00 amRNSNotice of Results
31st Oct 201711:11 amRNSHolding(s) in Company
26th Oct 20173:59 pmRNSPublication of Circular and Notice of GM
5th Oct 20177:00 amRNSResults of placing
4th Oct 20174:40 pmRNSProposed fundraising of £8.6 million
19th Sep 20173:13 pmRNSNanoco CFQD® Fine Color FilmT at Touch Taiwan 2017
8th Sep 201710:34 amRNSCommercial Supply and License Agreement
7th Sep 201712:07 pmRNSSecond Price Monitoring Extn
7th Sep 201712:02 pmRNSPrice Monitoring Extension
29th Aug 20177:00 amRNSHolding(s) in Company
25th Aug 20174:17 pmRNSHolding(s) in Company
25th Aug 201712:52 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSFull Year Trading Update and Outlook
9th Aug 20177:00 amRNSEuropean Commission to Prohibit Cadmium
4th Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20177:00 amRNSDavid Yao joins Nanoco
7th Jul 20177:10 amRNSHolding(s) in Company
7th Jul 20177:00 amRNSHolding(s) in Company
5th Jul 20177:00 amRNSNanoco Awarded Grant from Innovate UK
3rd Jul 20173:33 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSNanoco presents at Samsung QLED & HDR10 Summit
30th Jun 20178:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSNanoco receives first commercial order
28th Jun 20174:16 pmRNSHolding(s) in Company
21st Jun 20179:18 amRNSHolding(s) in Company
14th Jun 20171:39 pmRNSHolding(s) in Company
14th Jun 20177:00 amRNSBlock listing Interim Review
22nd May 20178:50 amRNSHolding(s) in Company
22nd May 20177:00 amRNSNanoco and Kyulux Inc. Sign Agreement
15th May 20177:00 amRNSHolding(s) in Company
11th May 20171:57 pmRNSHolding(s) in Company
10th May 201710:11 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSDirectorate Change
4th Apr 20176:22 pmRNSHolding(s) in Company
4th Apr 201712:00 pmRNSHolding(s) in Company
4th Apr 20177:00 amRNSInterim Results
30th Mar 20177:00 amRNSWebcast of Interim Results
6th Mar 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.